Lexaria Bioscience (CSE: LXX) (OTCQX: LXRP) recently
announced that its wholly owned subsidiary, Lexaria Nicotine LLC, has joined
forces with one of the world’s largest tobacco companies to fund the research
and development of Lexaria’s patented DehydraTECHÔ technology to potentially
commercialize a form of oral nicotine delivery. An article discussing the
company reads, “Lexaria’s goal is to create an oral product that eliminates the
need for inhalation and helps curb the smoking habits of consumers. Over 6
million deaths a year worldwide are attributed to nicotine delivery through
smoking. The company believes that its DehydraTECH technology may help the 69
percent of U.S. adult smokers who want to quit move from cigarettes to a safer,
more effective delivery of nicotine (http://ibn.fm/Aps9F). This new partnership allows for
further research and development into oral, reduced-risk nicotine consumer
products.”
To view the full article, visit http://ibn.fm/uvA3e
About Lexaria Bioscience Corp.
Lexaria Bioscience has developed and out-licenses its
disruptive delivery technology that promotes healthier ingestion methods, lower
overall dosing and quicker onset of lipophilic active molecules. Lexaria has 10
patents granted in the United States and Australia, and has filed over 50
patent applications worldwide across 10 patent families. Lexaria’s technology
provides more rapid delivery to the bloodstream, as well as important
taste-masking benefits for orally administered bioactive molecules including
cannabinoids, vitamins, nonsteroidal anti-inflammatory drugs (NSAIDs), nicotine
and other molecules. For more information, visit the company’s website at www.LexariaBioscience.com.
About QualityStocksNewsBreaks
QualityStocksNewsBreaks provide
a rapid summary of corporate news that catch the attention of QualityStocks.
QualityStocksBreaks are designed to keep investors up to date on important and
breaking news in the small-cap and micro-cap markets. Spanning all industries,
including energy, entertainment, telecommunications, healthcare, retail and
more, these news breaks deliver opportunities the investment community may have
missed. Whether it is earnings results, mergers and acquisitions, or any other
market-moving news, our news breaks keep you in the know. QualityStocks is
committed to connecting subscribers with companies that have huge potential to
succeed in the short and long-term future. It is part of our mission statement
to help the investment community discover emerging companies that offer
excellent growth potential.
QualityStocks (QS)
Scottsdale, Arizona
www.QualityStocks.com
480.374.1336 Office
Editor@QualityStocks.com
Scottsdale, Arizona
www.QualityStocks.com
480.374.1336 Office
Editor@QualityStocks.com
Please see full terms of use and disclaimers on the
QualityStocks website applicable to all content provided by QS, wherever
published or re-republished: http://www.qualitystocks.net/disclaimer.php
No comments:
Post a Comment